Captrust Financial Advisors Akouos, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$2.46 - $5.2 $20,664 - $43,680	-8,400 Reduced 98.82%	100 $0
Q1 2022 May 16, 2022	BUY	$4.16 - $9.08 $33,795 - $73,765	8,124 Added 2160.64%	8,500 $40,000
Q4 2021 Feb 14, 2022	SELL	$7.65 - $11.38 $46,458 - $69,110	-6,073 Reduced 94.17%	376 $3,000
Q3 2021 Nov 16, 2021	BUY	$9.93 - $13.59 $40,434 - $55,338	4,072 Added 171.31%	6,449 $75,000
Q2 2021 Aug 16, 2021	BUY	$11.87 - $15.96 $28,214 - $37,936	2,377 New	2,377 $30,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.